{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:27:49Z","timestamp":1785256069988,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"am","delay-in-days":264,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0231"],"award-info":[{"award-number":["W81XWH-18-1-0231"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008333","name":"University of Alabama at Birmingham","doi-asserted-by":"publisher","award":["T-32-CA047888"],"award-info":[{"award-number":["T-32-CA047888"]}],"id":[{"id":"10.13039\/100008333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011531","name":"University of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ygyno.2024.02.008","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T02:38:44Z","timestamp":1708396724000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment"],"prefix":"10.1016","volume":"185","author":[{"given":"Carly B.","family":"Scalise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Kincaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Thigpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennah","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailee","family":"Dover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyse","family":"Norian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Meza-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Birrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunle","family":"Odunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Arend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2024.02.008_bb0010","first-page":"20(4)","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2024.02.008_bb0015","series-title":"SEER*Explorer: An interactive website for SEER statistics [Internet]","year":"2021"},{"key":"10.1016\/j.ygyno.2024.02.008_bb0020","series-title":"Medical Treatment for Relapsed Epithelial Ovarian, Fallopian Tube, or Peritoneal cancer: Platinum-Resistant Disease","author":"Birrer","year":"2021"},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.008_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12032-017-0960-z","article-title":"A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer","volume":"34","author":"Oronsky","year":"2017","journal-title":"Med. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.02.008_bb0030","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1158\/1078-0432.CCR-21-2984","article-title":"Metabolic alterations and WNT signaling impact immune response in HGSOC","volume":"28","author":"Arend","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic analyses reveal genotype-Immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"issue":"20","key":"10.1016\/j.ygyno.2024.02.008_bb0040","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2043-9113-3-22","article-title":"PROGgene: gene expression based survival analysis web application for multiple cancers","volume":"3","author":"Goswami","year":"2013","journal-title":"J Clin Bioinforma"},{"issue":"22","key":"10.1016\/j.ygyno.2024.02.008_bb0050","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1073\/pnas.220413597","article-title":"Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase a","volume":"97","author":"Fang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.008_bb0055","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4049\/jimmunol.2000136","article-title":"Cutting edge: inhibition of glycogen synthase kinase 3 activity induces the generation and enhanced suppressive function of human IL-10(+) FOXP3(+)-induced regulatory T cells","volume":"205","author":"Cheng","year":"2020","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.02.008_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200905153","article-title":"The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins","volume":"186","author":"Merino","year":"2009","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.02.008_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imm.12123","article-title":"Kinase AKT controls innate immune cell development and function","volume":"140","author":"Zhang","year":"2013","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2020.06.009","article-title":"Interferon-independent Activites of mammalian STING mediate antiviral response and tumor immune evasion","volume":"53","author":"Wu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ygyno.2024.02.008_bb0075","first-page":"239083","article-title":"Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation","volume":"2010","author":"Placke","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ygyno.2024.02.008_bb0080","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in Cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.02.008_bb0085","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.ygyno.2024.02.008_bb0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jcb.25091","article-title":"The upregulation of PI3K\/Akt and MAP kinase pathways is associated with resistance of microtubule-targeting drugs in prostate Cancer","volume":"116","author":"Liu","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12967-020-02306-y","article-title":"Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy","volume":"18","author":"Raza","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ygyno.2024.02.008_bb0100","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.2147\/OTT.S214211","article-title":"OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer","volume":"12","author":"Deng","year":"2019","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.ygyno.2024.02.008_bb0105","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","article-title":"S100 proteins as an important regulator of macrophage inflammation","volume":"8","author":"Xia","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1097-0142(19990225)87:1<37::AID-CNCR7>3.0.CO;2-7","article-title":"Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration","volume":"87","author":"Fetsch","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4048\/jbc.2014.17.1.40","article-title":"Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients","volume":"17","author":"Kim","year":"2014","journal-title":"J. Breast Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0120","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1038\/s41598-017-17265-6","article-title":"The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ygyno.2024.02.008_bb0125","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","article-title":"VISTA is an immune checkpoint molecule for human T cells","volume":"74","author":"Lines","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12964-019-0471-y","article-title":"The regulatory roles of neutrophils in adaptive immunity","volume":"17","author":"Li","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ygyno.2024.02.008_bb0135","first-page":"13(22)","article-title":"High poly(ADP-ribose) polymerase expression does relate to poor survival in solid cancers: a systematic review and meta-analysis","author":"Thakur","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2024.02.008_bb0140","first-page":"13(9)","article-title":"Homologous recombination repair deficiency and implications for tumor immunogenicity","author":"van Wilpe","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ygyno.2024.02.008_bb0145","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.4049\/jimmunol.1100891","article-title":"Granzyme B regulates antiviral CD8+ T cell responses","volume":"187","author":"Salti","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2024.02.008_bb0150","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3389\/fimmu.2020.02135","article-title":"HGF-MET signaling shifts M1 macrophages toward an M2-like phenotype through PI3K-mediated induction of Arginase-1 expression","volume":"11","author":"Nishikoba","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.02.008_bb0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/21645515.2017.1395995","article-title":"Effects of STING stimulation on macrophages: STING agonists polarize into \u201cclassically\u201d or \u201calternatively\u201d activated macrophages?","volume":"14","author":"Ohkuri","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ygyno.2024.02.008_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4419-1599-3_2","article-title":"FOXP3 and its role in the immune system","volume":"665","author":"Kim","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0889-857X(03)00116-9","article-title":"Vascular endothelium and immune responses: implications for inflammation and angiogenesis","volume":"30","author":"Szekanecz","year":"2004","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"1","key":"10.1016\/j.ygyno.2024.02.008_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/wound.2019.1019","article-title":"A role for low-density lipoprotein receptor-related protein 6 in blood vessel regression in wound healing","volume":"9","author":"Michalczyk","year":"2020","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"6","key":"10.1016\/j.ygyno.2024.02.008_bb0175","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s12282-019-00977-0","article-title":"Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive\/HER2-negative operated breast cancers","volume":"26","author":"Fujimoto","year":"2019","journal-title":"Breast Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2024.02.008_bb0180","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.18632\/oncotarget.3307","article-title":"Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment","volume":"6","author":"Ip","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2024.02.008_bb0185","doi-asserted-by":"crossref","first-page":"41962","DOI":"10.1038\/srep41962","article-title":"PARP-1\/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas","volume":"7","author":"Navarro","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582400088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582400088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:35:32Z","timestamp":1732610132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582400088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":37,"alternative-id":["S009082582400088X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.02.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}